SMC approves tapentadol for NHS Scotland

GPs in Scotland can now prescribe tapentadol prolonged release on the NHS following a Scottish Medicines Consortium review.

The review body approved use of tapentadol prolonged release (Palexia SR) for the management of severe chronic pain in adults that can be adequately managed only with opioid analgesics.

Its use is restricted to patients in whom morphine sulphate modified release has failed to provide adequate pain control or is not tolerated.

A meta-analysis of three studies suggest that tapentadol prolonged release has improved gastrointestinal tolerability and similar efficacy compared to another long-acting opioid included as an active control, the Scottish Medicines Consortium said.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us: